Since MYC is frequently amplified and/or overexpressed in human AML (13%) and in MDS which may develop AML later and was previously called as preleukemia, we constructed an Myc-induced murine AML model (S1A–S1C Fig) [13]. This evidence concerns the gene MYC and myelodysplastic syndrome.